Profil
David Liens is the founder of Bio-harma & Life-Sciences Consulting SRL, which was founded in 2012.
He held the title of General Manager at the time of founding.
Currently, he is the Chief Medical Officer at ElsaLys Biotech SAS, a position he has held since 2017.
Dr. Liens has previously worked as an International Medical Advisor at Merck KGaA, Head-Clinical Development at EUSA Pharma, Inc., and Chief Medical Officer at ERYTech Pharma SA from 2009 to 2012.
Dr. Liens holds a doctorate degree from the University of Lyon.
Aktiva positioner av David Liens
| Företag | Position | Start |
|---|---|---|
Bio -harma & Life-Sciences Consulting SRL
Bio -harma & Life-Sciences Consulting SRL Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Verkställande Direktör | 2012-01-01 |
Tidigare kända positioner av David Liens
| Företag | Position | Slut |
|---|---|---|
| ELSALYS BIOTECH | Teknisk/Vetenskaplig/F&U Direktör | - |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Företagsledare/Principal | - |
| MERCK KGAA | Företagsledare/Principal | - |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology Develops medicinal products for orphan oncology and rare diseases | Företagsledare/Principal | - |
David Lienss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Health Technology |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology Develops medicinal products for orphan oncology and rare diseases | Health Technology |
University of Lyon
University of Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ElsaLys Biotech SAS
ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology Designs, develops and supplies antibodies to modulate the immune system of patients | Health Technology |
Bio -harma & Life-Sciences Consulting SRL
Bio -harma & Life-Sciences Consulting SRL Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Commercial Services |
















